Cargando…
When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer’s and Huntington’s Disease
Alzheimer’s disease (AD) is a mostly sporadic brain disorder characterized by cognitive decline resulting from selective neurodegeneration in the hippocampus and cerebral cortex whereas Huntington’s disease (HD) is a monogenic inherited disorder characterized by motor abnormalities and psychiatric d...
Autor principal: | D’Mello, Santosh R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199025/ https://www.ncbi.nlm.nih.gov/pubmed/34072862 http://dx.doi.org/10.3390/ijms22115911 |
Ejemplares similares
-
When endothelial cells go rogue
por: Chen, Pei‐Yu, et al.
Publicado: (2015) -
For cdks, one is enough
por: Leslie, Mitch
Publicado: (2007) -
When upper respiratory tract infections go rogue: A case report of Arcanobacterium haemolyticum Cerebral Abscess
por: Adams, Nehkonti, et al.
Publicado: (2020) -
Cdks set the replication schedule
por: Leslie, Mitch
Publicado: (2010) -
The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma
por: García-Reyes, Balbina, et al.
Publicado: (2018)